-
公开(公告)号:US11858926B2
公开(公告)日:2024-01-02
申请号:US17871157
申请日:2022-07-22
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Joseph P. Lyssikatos , Fengmei Zheng , Matthew Peterson , Daniel B. Patience
IPC: C07D417/14 , C07D403/14 , C07D413/14 , C07D405/14 , C07D471/04 , A61P43/00 , A61P1/16
CPC classification number: C07D417/14 , A61P1/16 , A61P43/00 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07B2200/13
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US10961237B2
公开(公告)日:2021-03-30
申请号:US16534540
申请日:2019-08-07
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Joseph P. Lyssikatos , Fengmei Zheng , Matthew Peterson , Daniel B. Patience
IPC: C07D417/14 , C07D403/14 , C07D413/14 , C07D405/14 , C07D471/04 , A61P43/00 , A61P1/16
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US10899753B2
公开(公告)日:2021-01-26
申请号:US16410725
申请日:2019-05-13
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Jürgen Schulz , Marta Nevalainen , Michael Dechantsreiter
IPC: C07D413/14 , C07D403/14 , C07D405/14
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US20240083900A1
公开(公告)日:2024-03-14
申请号:US18036853
申请日:2021-11-12
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Isaac Marx , Jürgen Schulz , George Vandeveer , Robin Prince , Marta Nevalainen , TeYu Chen , Zain Yousaf , Martin Himmelbauer , Vatee Pattaropong , John Howard Jones , Edward Yin-Shiang Lin , Felix Gonzalez Lopez de Turiso , Thomas Purgett , Andrew George Capacci , Simone Sciabola
IPC: C07D487/04 , C07D471/04 , C07D519/00
CPC classification number: C07D487/04 , C07D471/04 , C07D519/00
Abstract: Provided are compounds of Formula (I′): or pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined herein; and methods for their use and production.
-
公开(公告)号:US20210340135A1
公开(公告)日:2021-11-04
申请号:US17183702
申请日:2021-02-24
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Joseph P. Lyssikatos , Fengmei Zheng , Matthew Peterson , Daniel B. Patience
IPC: C07D417/14 , C07D403/14 , C07D413/14 , A61P43/00 , C07D405/14 , C07D471/04 , A61P1/16
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US20180362522A1
公开(公告)日:2018-12-20
申请号:US16113455
申请日:2018-08-27
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Joseph P. Lyssikatos , Fengmei Zheng , Matthew Peterson , Daniel B. Patience
IPC: C07D417/14 , A61P43/00 , C07D403/14 , C07D405/14 , C07D413/14
CPC classification number: C07D417/14 , A61K31/44 , A61K31/443 , A61K31/506 , A61P43/00 , C07B2200/13 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US20190382394A1
公开(公告)日:2019-12-19
申请号:US16410725
申请日:2019-05-13
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Jürgen Schulz , Marta Nevalainen , Michael Dechantsreiter
IPC: C07D413/14 , C07D405/14 , C07D403/14
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US20180297992A1
公开(公告)日:2018-10-18
申请号:US15952505
申请日:2018-04-13
Applicant: BIOGEN MA INC.
Inventor: Brian T. Hopkins , Bin Ma , Robin Prince , Isaac Marx , Joseph P. Lyssikatos , Fengmei Zheng , Matthew Peterson , Daniel B. Patience
IPC: C07D417/14 , C07D403/14 , C07D405/14 , C07D413/14 , A61P43/00
CPC classification number: C07D417/14 , A61K31/44 , A61K31/443 , A61K31/506 , A61P43/00 , C07B2200/13 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04
Abstract: Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
-
公开(公告)号:US20250152574A1
公开(公告)日:2025-05-15
申请号:US18837245
申请日:2023-02-13
Applicant: BIOGEN MA INC.
Inventor: Martin Himmelbauer , Felix Gonzalez Lopez de Turiso , John H. Jones , Edward Yin Shiang Lin , Robin Prince , Vatee Pattaropong , Zhili Xin , TeYu Chen , Nupur Bansal
IPC: A61K31/4709 , A61K31/438 , A61P25/28 , C07D221/20 , C07D401/12 , C07D491/107
Abstract: Provided are compounds of the Formula (I) or pharmaceutically acceptable salts thereof, which are useful for the inhibition of EBP and in the treatment of a variety of EBP mediated conditions or diseases, such as multiple sclerosis.
-
公开(公告)号:US20220411429A1
公开(公告)日:2022-12-29
申请号:US17773471
申请日:2020-10-29
Applicant: BIOGEN MA INC.
Inventor: Isaac Marx , Jürgen Schulz , Brian T. Hopkins , Bin Ma , Robin Prince , Marta Nevalainen
IPC: C07D487/04 , C07D519/00
Abstract: Provided are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein ring A, R3, R4, R5, R6, A1, B1, B2, Q1 and Q2 are as defined herein; and methods for their use and production.
-
-
-
-
-
-
-
-
-